Literature DB >> 3821733

Characterization of the rearranged tpr-met oncogene breakpoint.

M Dean, M Park, G F Vande Woude.   

Abstract

We determined the nucleotide sequence of the rearranged trp-met genomic locus and the corresponding portions of the unrearranged tpr and met genomic fragments. The breakpoints occur at one end of a stretch of 21 A residues that follow an Alu repetitive sequence in the tpr locus and within a group of 3 A residues in the met proto-oncogene locus. We conclude that the fusion between the tpr locus on chromosome 1 and the met locus on chromosome 7 resulted from a recombination event.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3821733      PMCID: PMC365151          DOI: 10.1128/mcb.7.2.921-924.1987

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  29 in total

1.  Transformation of human cells in culture by N-methyl-N'-nitro-N-nitrosoguanidine.

Authors:  J S Rhim; D K Park; P Arnstein; R J Huebner; E K Weisburger; W A Nelson-Rees
Journal:  Nature       Date:  1975-08-28       Impact factor: 49.962

2.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

3.  The action of oncogenes in the cytoplasm and nucleus.

Authors:  R A Weinberg
Journal:  Science       Date:  1985-11-15       Impact factor: 47.728

4.  Heritable fragile sites on human chromosomes I. Factors affecting expression in lymphocyte culture.

Authors:  G R Sutherland
Journal:  Am J Hum Genet       Date:  1979-03       Impact factor: 11.025

5.  Screening lambdagt recombinant clones by hybridization to single plaques in situ.

Authors:  W D Benton; R W Davis
Journal:  Science       Date:  1977-04-08       Impact factor: 47.728

6.  A gene deletion ending at the midpoint of a repetitive DNA sequence in one form of hereditary persistence of fetal haemoglobin.

Authors:  P Jagadeeswaran; D Tuan; B G Forget; S M Weissman
Journal:  Nature       Date:  1982-04-01       Impact factor: 49.962

Review 7.  The origin of human cancers.

Authors:  J Cairns
Journal:  Nature       Date:  1981-01-29       Impact factor: 49.962

8.  Cytological detection of mutagen-carcinogen exposure by sister chromatid exchange.

Authors:  P Perry; H J Evans
Journal:  Nature       Date:  1975-11-13       Impact factor: 49.962

9.  Methylation of deoxyribonucleic acid in cultured mammalian cells by N-methyl-N'-nitro-N-nitrosoguanidine. The influence of cellular thiol concentrations on the extent of methylation and the 6-oxygen atom of guanine as a site of methylation.

Authors:  P D Lawley; C J Thatcher
Journal:  Biochem J       Date:  1970-02       Impact factor: 3.857

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  21 in total

1.  C-Met/miR-130b axis as novel mechanism and biomarker for castration resistance state acquisition.

Authors:  A Cannistraci; G Federici; A Addario; A L Di Pace; L Grassi; G Muto; D Collura; M Signore; L De Salvo; S Sentinelli; G Simone; M Costantini; S Nanni; A Farsetti; V Coppola; R De Maria; D Bonci
Journal:  Oncogene       Date:  2017-02-13       Impact factor: 9.867

2.  Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor.

Authors:  H Takayama; W J LaRochelle; R Sharp; T Otsuka; P Kriebel; M Anver; S A Aaronson; G Merlino
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

3.  Localization of preferential sites of rearrangement within the BCR gene in Philadelphia chromosome-positive acute lymphoblastic leukemia.

Authors:  C T Denny; N P Shah; S Ogden; C Willman; T McConnell; W Crist; A Carroll; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

4.  Structural Basis of TPR-Mediated Oligomerization and Activation of Oncogenic Fusion Kinases.

Authors:  Kuntal Pal; Abhishek Bandyopadhyay; X Edward Zhou; Qingping Xu; David P Marciano; Joseph S Brunzelle; Smitha Yerrum; Patrick R Griffin; George Vande Woude; Karsten Melcher; H Eric Xu
Journal:  Structure       Date:  2017-05-18       Impact factor: 5.006

5.  Nucleotide sequence of both reciprocal translocation junction regions in a patient with Ph positive acute lymphoblastic leukaemia, with a breakpoint within the first intron of the BCR gene.

Authors:  M J van der Feltz; M K Shivji; P B Allen; N Heisterkamp; J Groffen; L M Wiedemann
Journal:  Nucleic Acids Res       Date:  1989-01-11       Impact factor: 16.971

Review 6.  Biology of MET: a double life between normal tissue repair and tumor progression.

Authors:  Iacopo Petrini
Journal:  Ann Transl Med       Date:  2015-04

7.  C-met activation is necessary but not sufficient for liver colonization by B16 murine melanoma cells.

Authors:  S Lin; D Rusciano; P Lorenzoni; G Hartmann; W Birchmeier; S Giordano; P Comoglio; M M Burger
Journal:  Clin Exp Metastasis       Date:  1998-04       Impact factor: 5.150

8.  Disassociation of met-mediated biological responses in vivo: the natural hepatocyte growth factor/scatter factor splice variant NK2 antagonizes growth but facilitates metastasis.

Authors:  T Otsuka; J Jakubczak; W Vieira; D P Bottaro; D Breckenridge; W J Larochelle; G Merlino
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

Review 9.  Evolutionary conservation and expression of human RNA-binding proteins and their role in human genetic disease.

Authors:  Stefanie Gerstberger; Markus Hafner; Manuel Ascano; Thomas Tuschl
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

10.  Characterization of the TPR-MET oncogene p65 and the MET protooncogene p140 protein-tyrosine kinases.

Authors:  M Gonzatti-Haces; A Seth; M Park; T Copeland; S Oroszlan; G F Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.